Cargando…

Na(+)/H(+)-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells

Adoptive cell transfer (ACT) immunotherapy has remarkable efficacy against some hematologic malignancies. However, its efficacy in solid tumors is limited by the adverse tumor microenvironment (TME) conditions, most notably that acidity inhibits T and natural killer (NK) cell mTOR complex 1 (mTORC1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Yao-Yu, Shao, Hongguang, Li, Yu, Brafford, Patricia, Stine, Zachary E., Sun, Jing, Felsher, Dean W., Orange, Jordan S., Albelda, Steven M., Dang, Chi V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648415/ https://www.ncbi.nlm.nih.gov/pubmed/36380966 http://dx.doi.org/10.1158/2767-9764.CRC-22-0270

Ejemplares similares

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi
por: Schmidt, Stanislaw, et al.
Publicado: (2021)

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019)

Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model
por: Iaia, Ilenia, et al.
Publicado: (2022)

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
por: Navarrete-Galvan, Lydia, et al.
Publicado: (2022)

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity
por: Shin, Hyun Young, et al.
Publicado: (2023)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
por: Zhang, Congcong, et al.
Publicado: (2017)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
por: Romanski, Annette, et al.
Publicado: (2016)

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
por: Huang, Rih-Sheng, et al.
Publicado: (2020)

How I Manage Natural Killer Cell Deficiency
por: Orange, Jordan S.
Publicado: (2019)

Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis
por: Li, Yu, et al.
Publicado: (2021)

Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
por: Koopman, Louise A., et al.
Publicado: (2003)

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
por: Mantesso, Simone, et al.
Publicado: (2020)

Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2020)

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
por: Zhu, Liya, et al.
Publicado: (2017)

Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways
por: Salazar-Mather, Thais P., et al.
Publicado: (1998)

An integrated workflow for phosphopeptide identification in natural killer cells (NK-92MI) and their targets (MDA-MB-231) during immunological synapse formation
por: Perez-Hernandez, Daniel, et al.
Publicado: (2023)

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases
por: Grote, Stefan, et al.
Publicado: (2021)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy
por: Guo, Meng, et al.
Publicado: (2021)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Limited response of NK92 cells to Plasmodium falciparum-infected erythrocytes
por: de Carvalho, Elisandra Grangeiro, et al.
Publicado: (2011)

Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

Dual channel STED nanoscopy of lytic granules on actin filaments in natural killer cells
por: Mace, Emily M., et al.
Publicado: (2012)

Editorial: NK Cell Subsets in Health and Disease: New Developments
por: Marcenaro, Emanuela, et al.
Publicado: (2017)

Corrigendum: Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
por: Chrobok, Michael, et al.
Publicado: (2019)

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
por: Cao, Bihui, et al.
Publicado: (2021)

4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
por: Schmit, Megan, et al.
Publicado: (2020)

Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting
por: Grote, Stefan, et al.
Publicado: (2020)

New views of the human NK cell immunological synapse: recent advances enabled by super- and high-resolution imaging techniques
por: Mace, Emily M., et al.
Publicado: (2013)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
por: LI, JIANG, et al.
Publicado: (2012)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ld1cghvr7p7gidme5d5at1utf